Patent details

EP1841781 Title: IL-22 FOR USE IN THE TREATMENT OF OBESITY, DIABETES, HYPERLIPIDEMIA, HYPERGLYCEMIA AND HYPERINSULINEMIA

Basic Information

Publication number:
EP1841781
PCT Application Number:
PCT/US/2005/028186
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057844193
PCT Publication Number:
WO/2006/073508
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IL-22 FOR USE IN THE TREATMENT OF OBESITY, DIABETES, HYPERLIPIDEMIA, HYPERGLYCEMIA AND HYPERINSULINEMIA
French Title of Invention:
UTILISATION DE L'IL-22 POUR LE TRAITEMENT DE L'OBÉSITÉ, LA DIABÈTE, L'HYPERLIPÉMIE, L'HYPERGLYCÉMIE ET L'HYPERINSULINISME
German Title of Invention:
IL-22 ZUR BEHANDLUNG VON FETTLEIBIGKEIT, DIABETES, HYPERLIPIDÄMIE, HYPERGLYKÄMIE UND INSULINRESISTENZ
SPC Number:

Dates

Filing date:
08/08/2005
Grant date:
06/04/2011
EP Publication Date:
06/04/2011
PCT Publication Date:
13/07/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2007
EP B1 Publication Date:
06/04/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/08/2011
Expiration date:
08/08/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/08/2005
 
 

Name:
Generon (Shanghai) Corp.
Address:
Suite 302/303, Building 9 1011 Ha Lei Road, Z.J. Hi-Tech Park Shanghai 201203, China (CN)

Inventor

1

Name:
CHEN Xu, Wen
Address:
United States (US)

2

Name:
HUANG Yu, Liang
Address:
United States (US)

Priority

Priority Number:
200510023103
Priority Date:
04/01/2005
Priority Country:
China (CN)

Classification

Main IPC Class:
C07K 1/00;
Filing date Document type Number of pages